Brain ischemia augments exo-focal transgene expression of adenovirus-mediated gene transfer to ependyma in hypertensive rats

Yasuhiro Kumai, Hiroaki Ooboshi, Takanari Kitazono, Junichi Takada, Setsuro Ibayashi, Masatoshi Fujishima, Mitsuo Iida

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The ependyma is one of the feasible targets for gene transfer to the brain. Using two different replication-deficient recombinant adenoviral vectors, AdCMVβGal or AdRSVIL10, we examined effects of cortical brain ischemia on transgene expression in the ependyma after administration of the vector into the lateral ventricle of spontaneously hypertensive rats (SHR). Expression of the reporter gene lacZ at the lateral ventricle was detected by histochemistry for semiquantitative scoring or by biochemical assay for quantitative analysis. Ependymal cells in the ventricles expressed the transgene as early as 6 h after gene transfer in both sham treatment and ischemia treatment. In the sham treatment, the expression peaked at 12 h and slowly decreased toward day 4 and day 7. However, transgene expressions in the ischemic brain on day 4 and day 7 were significantly higher than sham treatment. In the biochemical assay, β-galactosidase activity detected on day 4 at the periventricular area of the ischemic group (37 ± 9 mU/mg protein) was significantly greater than that of the sham group (12 ± 4, P < 0.01). In the enzyme-linked immunosorbent assay for gene transfer of interleukin-10 (IL-10), IL-10 in the cerebrospinal fluid (CSF) of the ischemic group (11,633 ± 4322 pg/ml) was significantly greater than that in the sham group (2460 ± 1486, P < 0.05) on day 5. These results suggest that transgene expression in the exo-focal remote area of ependyma is augmented by cortical ischemia, and the ependyma may be a promising target of gene transfer of brain ischemia.

Original languageEnglish
Pages (from-to)904-911
Number of pages8
JournalExperimental Neurology
Volume184
Issue number2
DOIs
Publication statusPublished - Jan 1 2003

Fingerprint

Ependyma
Brain Ischemia
Transgenes
Adenoviridae
Lateral Ventricles
Placebos
Interleukin-10
Genes
Ischemia
Galactosidases
Brain
Inbred SHR Rats
Reporter Genes
Cerebrospinal Fluid
Enzyme-Linked Immunosorbent Assay
Proteins

All Science Journal Classification (ASJC) codes

  • Neurology
  • Developmental Neuroscience

Cite this

Brain ischemia augments exo-focal transgene expression of adenovirus-mediated gene transfer to ependyma in hypertensive rats. / Kumai, Yasuhiro; Ooboshi, Hiroaki; Kitazono, Takanari; Takada, Junichi; Ibayashi, Setsuro; Fujishima, Masatoshi; Iida, Mitsuo.

In: Experimental Neurology, Vol. 184, No. 2, 01.01.2003, p. 904-911.

Research output: Contribution to journalArticle

Kumai, Yasuhiro ; Ooboshi, Hiroaki ; Kitazono, Takanari ; Takada, Junichi ; Ibayashi, Setsuro ; Fujishima, Masatoshi ; Iida, Mitsuo. / Brain ischemia augments exo-focal transgene expression of adenovirus-mediated gene transfer to ependyma in hypertensive rats. In: Experimental Neurology. 2003 ; Vol. 184, No. 2. pp. 904-911.
@article{005694c43ee04842a087397a6fc548f7,
title = "Brain ischemia augments exo-focal transgene expression of adenovirus-mediated gene transfer to ependyma in hypertensive rats",
abstract = "The ependyma is one of the feasible targets for gene transfer to the brain. Using two different replication-deficient recombinant adenoviral vectors, AdCMVβGal or AdRSVIL10, we examined effects of cortical brain ischemia on transgene expression in the ependyma after administration of the vector into the lateral ventricle of spontaneously hypertensive rats (SHR). Expression of the reporter gene lacZ at the lateral ventricle was detected by histochemistry for semiquantitative scoring or by biochemical assay for quantitative analysis. Ependymal cells in the ventricles expressed the transgene as early as 6 h after gene transfer in both sham treatment and ischemia treatment. In the sham treatment, the expression peaked at 12 h and slowly decreased toward day 4 and day 7. However, transgene expressions in the ischemic brain on day 4 and day 7 were significantly higher than sham treatment. In the biochemical assay, β-galactosidase activity detected on day 4 at the periventricular area of the ischemic group (37 ± 9 mU/mg protein) was significantly greater than that of the sham group (12 ± 4, P < 0.01). In the enzyme-linked immunosorbent assay for gene transfer of interleukin-10 (IL-10), IL-10 in the cerebrospinal fluid (CSF) of the ischemic group (11,633 ± 4322 pg/ml) was significantly greater than that in the sham group (2460 ± 1486, P < 0.05) on day 5. These results suggest that transgene expression in the exo-focal remote area of ependyma is augmented by cortical ischemia, and the ependyma may be a promising target of gene transfer of brain ischemia.",
author = "Yasuhiro Kumai and Hiroaki Ooboshi and Takanari Kitazono and Junichi Takada and Setsuro Ibayashi and Masatoshi Fujishima and Mitsuo Iida",
year = "2003",
month = "1",
day = "1",
doi = "10.1016/j.expneurol.2003.08.022",
language = "English",
volume = "184",
pages = "904--911",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Brain ischemia augments exo-focal transgene expression of adenovirus-mediated gene transfer to ependyma in hypertensive rats

AU - Kumai, Yasuhiro

AU - Ooboshi, Hiroaki

AU - Kitazono, Takanari

AU - Takada, Junichi

AU - Ibayashi, Setsuro

AU - Fujishima, Masatoshi

AU - Iida, Mitsuo

PY - 2003/1/1

Y1 - 2003/1/1

N2 - The ependyma is one of the feasible targets for gene transfer to the brain. Using two different replication-deficient recombinant adenoviral vectors, AdCMVβGal or AdRSVIL10, we examined effects of cortical brain ischemia on transgene expression in the ependyma after administration of the vector into the lateral ventricle of spontaneously hypertensive rats (SHR). Expression of the reporter gene lacZ at the lateral ventricle was detected by histochemistry for semiquantitative scoring or by biochemical assay for quantitative analysis. Ependymal cells in the ventricles expressed the transgene as early as 6 h after gene transfer in both sham treatment and ischemia treatment. In the sham treatment, the expression peaked at 12 h and slowly decreased toward day 4 and day 7. However, transgene expressions in the ischemic brain on day 4 and day 7 were significantly higher than sham treatment. In the biochemical assay, β-galactosidase activity detected on day 4 at the periventricular area of the ischemic group (37 ± 9 mU/mg protein) was significantly greater than that of the sham group (12 ± 4, P < 0.01). In the enzyme-linked immunosorbent assay for gene transfer of interleukin-10 (IL-10), IL-10 in the cerebrospinal fluid (CSF) of the ischemic group (11,633 ± 4322 pg/ml) was significantly greater than that in the sham group (2460 ± 1486, P < 0.05) on day 5. These results suggest that transgene expression in the exo-focal remote area of ependyma is augmented by cortical ischemia, and the ependyma may be a promising target of gene transfer of brain ischemia.

AB - The ependyma is one of the feasible targets for gene transfer to the brain. Using two different replication-deficient recombinant adenoviral vectors, AdCMVβGal or AdRSVIL10, we examined effects of cortical brain ischemia on transgene expression in the ependyma after administration of the vector into the lateral ventricle of spontaneously hypertensive rats (SHR). Expression of the reporter gene lacZ at the lateral ventricle was detected by histochemistry for semiquantitative scoring or by biochemical assay for quantitative analysis. Ependymal cells in the ventricles expressed the transgene as early as 6 h after gene transfer in both sham treatment and ischemia treatment. In the sham treatment, the expression peaked at 12 h and slowly decreased toward day 4 and day 7. However, transgene expressions in the ischemic brain on day 4 and day 7 were significantly higher than sham treatment. In the biochemical assay, β-galactosidase activity detected on day 4 at the periventricular area of the ischemic group (37 ± 9 mU/mg protein) was significantly greater than that of the sham group (12 ± 4, P < 0.01). In the enzyme-linked immunosorbent assay for gene transfer of interleukin-10 (IL-10), IL-10 in the cerebrospinal fluid (CSF) of the ischemic group (11,633 ± 4322 pg/ml) was significantly greater than that in the sham group (2460 ± 1486, P < 0.05) on day 5. These results suggest that transgene expression in the exo-focal remote area of ependyma is augmented by cortical ischemia, and the ependyma may be a promising target of gene transfer of brain ischemia.

UR - http://www.scopus.com/inward/record.url?scp=0842342525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842342525&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2003.08.022

DO - 10.1016/j.expneurol.2003.08.022

M3 - Article

C2 - 14769382

AN - SCOPUS:0842342525

VL - 184

SP - 904

EP - 911

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 2

ER -